Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Diffuse midline glioma (DIPG)
H3 K27-altered tumours of the brainstem and midline, with no curative treatment: ONC201 and cell therapy trials.
AACR Annual Meeting 2026
17–22 Apr 2026, San Diego · Cancer Research 86 (7_Supplement)
All 7,489 abstracts, including clinical trial (CT) and late-breaking (LB) abstracts, have Cancer Research supplement DOIs in Crossref.
Indexed in Crossref
10 abstracts matching diffuse midline glioma (dipg) from the meeting's journal supplement, fetched live from Crossref 2026-11-12 08:20 UTC. This is a keyword search, not the complete abstract book.
- 1170Proton-induced exosomal signatures reveal radiation response pathways in pediatric diffuse midline glioma.Ann Morcos, Yeonkyu Jung, Nathan R. Wall
- 2834Identification of CXCL10-CXCR3 axes as mediators of radioresistance in diffuse midline glioma (DMG)Mostafa M. Ibrahim, Niloofar Khairkhah, Carl Koschmann, Yue Zhao et al.
- 335Inhibition study of protein kinase C-iota mediated signaling pathways in diffuse midline glioma by ICA-1S inhibitor and temozolomide.Radwan Ebna Noor, Nuzhat Nowshin Oishee, Abir Hasib Shourav, Mahfuza Marzan et al.
- 199Identification of oncohistone-dependent changes in chromatin accessibility and the tumor microenvironment in a new inducible and reversible H3.3K27M mouse model of diffuse midline glioma (DMG).Mostafa M. Ibrahim, Niloofar Khairkhah, Sienna L. Galban, Megan Faunce et al.
- 6463Longitudinal single-cell atlas of GD2-CAR T cell therapy in H3K27M-mutant diffuse midline glioma identifies humoral and cellular anti-CAR immunityYiyun Chen, Kun-Wei Song, Moksha H. Desai, Ying-Wen Huang et al.
- 1270Immunotoxin GB13 Targets GBM and H3.3K27M DIPG with the activation of Golgi-to-ER retrograde transport pathways.Nanyun Tang, Yue Hao, Valerie DeLuca, Charles Caleb Shaffer et al.
- 7380TP53 mutants cooperate with H3K27M to enhance survival after DNA damage and drive radioresistance in DIPGKarol A. Arizaca Maquera, Viral Oza, Andrew Gaines, Colin Williams et al.
- 644Evaluating GD2-targeting antibody-drug conjugates for DIPG using human organoid-based preclinical platforms.Zhikun Wang, Emily Miller, Wei Huang, Satoru Kawakita et al.
- 6184Site-specific tumor modeling: DIPG and meningioma in miceMelissa Tran, Cheryl Davis, Ben Hoerner, Victoria Caruso et al.
- 1150Combining CDK4/6 inhibitor with TMZ and radiation alters cell states for synergistic responses in orthotopic DIPG modelsZilu Huang, Tongchao Jiang, Milagros M. Suarez Palacios, Tommy Ouyang et al.